William Blair analyst Brandon Vazquez has maintained their bullish stance on ALGN stock, giving a Buy rating on May 5.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Brandon Vazquez has given his Buy rating due to a combination of factors that highlight Align Tech’s strategic positioning and growth potential. The company’s recent 2025 investor day presentation emphasized its transition into a new phase, characterized by an extensive range of clinical capabilities and pricing strategies that enhance margins. This is particularly compelling given that the market for Invisalign is still largely untapped, with only 20% penetration, presenting significant growth opportunities.
Moreover, Align Tech is poised to expand its market share through innovative software features that aim to establish Invisalign as the standard of care in restorative dental cases, which represents a $10 billion incremental total addressable market. The company’s strategy to train more dentists globally, increase product utilization, and enhance brand awareness further supports this outlook. Despite current macroeconomic uncertainties, the company’s global reach and expanding portfolio provide a stable foundation, making the current valuation an attractive risk/reward proposition with potential for profit and loss and valuation upside.
In another report released on May 5, Piper Sandler also maintained a Buy rating on the stock with a $250.00 price target.